Novel Protein Biomarkers of Monoamine Metabolism Defects Correlate with Disease Severity

Trislan-Noguero A., Borras E., Molero-Luis M., Wassenberg T., Peters T., Verbeek M. M., ...Daha Fazla

MOVEMENT DISORDERS, cilt.36, ss.690-703, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 36
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1002/mds.28362
  • Dergi Adı: MOVEMENT DISORDERS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.690-703
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background Genetic defects of monoamine neurotransmitters are rare neurological diseases amenable to treatment with variable response. They are major causes of early parkinsonism and other spectrum of movement disorders including dopa-responsive dystonia.